Rogaratinib
Rogaratinib (BAY1163877) is a potent, selective, and orally bioavailable small molecule inhibitor targeting FGFR1, FGFR2, and FGFR3 kinase activity. It is widely used in preclinical research to investigate FGFR-driven pathologies, including in studies of cancer cell proliferation and tumor growth in both cellular and animal models.
Product Specifications
CAS Number
1443530-05-9
Product Name Alternative
BAY1163877, BAY-1163877, BAY 1163877, Inhibitor, FGFR4, FGFR3, FGFR2, FGFR, FGFR1, Fibroblast growth factor receptor, inhibit, Rogaratinib
Field of Research
Cardiovascular Research, Signal Transduction
Purity
99.54% (May vary between batches)
Solubility
DMSO:5.5 mg/mL (11.79 mM)
Smiles
COCc1c (CN2CCNC (=O) C2) n2ncnc (N) c2c1-c1cc2cc (C) cc (OC) c2s1
Molecular Formula
C23H26N6O3S
Molecular Weight
466.56
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRV-0022148-01 200 µL
FITC-Linked Polyclonal Antibody to Estrogen Receptor Beta (ERb)
Sign In for Pricing
View Details 
TRV-0022148-02 1 mL
FITC-Linked Polyclonal Antibody to Estrogen Receptor Beta (ERb)
Sign In for Pricing
View Details NBP3-18479JF669 0.1 mL
Rabbit Polyclonal CLE7 homolog Antibody [Janelia Fluor 669]
Sign In for Pricing
View Details